Green Christopher D, Jump Donald B, Olson L Karl
Departments of Physiology, Michigan State University, East Lansing, Michigan 48824-3320, USA.
Endocrinology. 2009 Jun;150(6):2637-45. doi: 10.1210/en.2008-1039. Epub 2009 Feb 19.
Increased basal and loss of glucose-stimulated insulin secretion (GSIS) are hallmarks of beta-cell dysfunction associated with type 2 diabetes. It has been proposed that elevated glucose promotes insulin secretory defects by activating sterol regulatory element binding protein (SREBP)-1c, lipogenic gene expression, and neutral lipid storage. Activation of liver X receptors (LXRs) also activates SREBP-1c and increases lipogenic gene expression and neutral lipid storage but increases basal and GSIS. This study was designed to characterize the changes in de novo fatty acid and triacylglyceride (TAG) synthesis in LXR-activated beta-cells and determine how these changes contribute to elevated basal and GSIS. Treatment of INS-1 beta-cells with LXR agonist T0901317 and elevated glucose led to markedly increased nuclear localization of SREBP-1, lipogenic gene expression, de novo synthesis of monounsaturated fatty acids and TAG, and basal and GSIS. LXR-activated cells had increased fatty acid oxidation and expression of genes involved in mitochondrial beta-oxidation, particularly carnitine palmitoyltransferase-1. Increased basal insulin release from LXR-activated cells coincided with rapid turnover of newly synthesized TAG and required acyl-coenzyme A synthesis and mitochondrial beta-oxidation. GSIS from LXR-activated INS-1 cells required influx of extracellular calcium and lipolysis, suggesting production of lipid-signaling molecules from TAG. Inhibition of diacylglyceride (DAG)-binding proteins, but not classic isoforms of protein kinase C, attenuated GSIS from LXR-activated INS-1 cells. In conclusion, LXR activation in beta-cells exposed to elevated glucose concentrations increases de novo TAG synthesis; subsequent lipolysis produces free fatty acids and DAG, which are oxidized to increase basal insulin release and activate DAG-binding proteins to enhance GSIS, respectively.
基础胰岛素分泌增加以及葡萄糖刺激的胰岛素分泌(GSIS)丧失是2型糖尿病相关β细胞功能障碍的标志。有人提出,升高的葡萄糖通过激活固醇调节元件结合蛋白(SREBP)-1c、脂肪生成基因表达和中性脂质储存来促进胰岛素分泌缺陷。肝X受体(LXR)的激活也会激活SREBP-1c并增加脂肪生成基因表达和中性脂质储存,但会增加基础胰岛素分泌和GSIS。本研究旨在表征LXR激活的β细胞中从头脂肪酸和三酰甘油(TAG)合成的变化,并确定这些变化如何导致基础胰岛素分泌增加和GSIS升高。用LXR激动剂T0901317处理INS-1β细胞并升高葡萄糖水平,导致SREBP-1的核定位显著增加、脂肪生成基因表达、单不饱和脂肪酸和TAG的从头合成以及基础胰岛素分泌和GSIS升高。LXR激活的细胞脂肪酸氧化增加,参与线粒体β氧化的基因表达增加,尤其是肉碱棕榈酰转移酶-1。LXR激活的细胞基础胰岛素释放增加与新合成TAG的快速周转同时发生,并且需要酰基辅酶A合成和线粒体β氧化。LXR激活的INS-1细胞的GSIS需要细胞外钙内流和脂解作用,提示TAG产生脂质信号分子。抑制二酰甘油(DAG)结合蛋白,但不抑制蛋白激酶C的经典亚型,可减弱LXR激活的INS-1细胞的GSIS。总之,在暴露于高葡萄糖浓度的β细胞中,LXR激活会增加TAG的从头合成;随后的脂解作用产生游离脂肪酸和DAG,它们分别被氧化以增加基础胰岛素释放并激活DAG结合蛋白以增强GSIS。